Evidence map›Paper›PMID 38831308›Full record

ArticleBMC nephrology2024

Rapidly progressive cognitive impairment resulting in heavy psychosocial burden in a patient with Fabry disease undergoing hemodialysis: a case report.

Isao Ohsawa, Akiko Onuki, Fumie Oka, Yoshiyuki Matsuoka, Yuko Makita, Takashi Kobayashi, Yasuhiko Kanaguchi, Yuya Nakamura, Yusuke Suzuki, Yoshikazu Goto and 1 more

Abstract readCase Reports
In one paragraph

Article in BMC nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Isao OhsawaDepartment of Nephrology, Internal Medicine, Saiyu Soka Hospital, 1-7-22, Matsubara, Soka City, Saitama, 340-0041, Japan. i.osawa@saiyukai.com.
Akiko OnukiDepartment of Rehabilitation, Saiyu Soka Hospital, Soka City, Saitama, Japan.
Fumie OkaDepartment of Rehabilitation, Saiyu Soka Hospital, Soka City, Saitama, Japan.
Yoshiyuki MatsuokaDepartment of Neurosurgery, Saiyu Soka Hospital, Soka City, Saitama, Japan.
Yuko MakitaDivision of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Bunkyo-Ku, Tokyo, Japan.
Takashi KobayashiDivision of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Bunkyo-Ku, Tokyo, Japan.
Yasuhiko KanaguchiDivision of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Bunkyo-Ku, Tokyo, Japan.
Yuya NakamuraDepartment of Nephrology, Internal Medicine, Saiyu Soka Hospital, 1-7-22, Matsubara, Soka City, Saitama, 340-0041, Japan.
Yusuke SuzukiDivision of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Bunkyo-Ku, Tokyo, Japan.
Yoshikazu GotoDepartment of Neurosurgery, Saiyu Soka Hospital, Soka City, Saitama, Japan.
Hiromichi GotohDepartment of Nephrology, Internal Medicine, Saiyu Soka Hospital, 1-7-22, Matsubara, Soka City, Saitama, 340-0041, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong-term enzyme replacement therapy (ERT) may improve prognosis in the patients with Fabry disease (FD), however, detail psychosocial burden has not been focused on long life expectancy. We experienced a male case of FD under ERT, he was placed on hemodialysis and presented rapidly progressive cognitive function. CASE PRESENTATION: A 51-year-old male patient with FD has been receiving ERT from age of 38 years. Hemodialysis was initiated at the age of 47 years. The patient experienced several attacks of cerebral infarction, and brain images demonstrated wide-spread asymptomatic ischemic lesions. His behavior became problematic at the age of 51 years. He often exhibited restlessness during hemodialysis sessions and failure to communicate effectively. The patient experienced impairment of attention and executive function, topographical disorientation, and amnesia. Consequently, it was necessary for medical staff and family members to monitor his behavior for safe extracorporeal circulation and daily life activities. Annual standardized neuropsychiatric testing revealed worsening of cognitive performance.

conclusionsDespite treating with long-term ERT, it is necessary to determine the psychosocial burden derived from the progression of cognitive impairment in patients with FD undergoing hemodialysis.

Indexed as

Cognitive DysfunctionEnzyme Replacement TherapyFabry DiseaseRenal DialysisCost of IllnessDisease ProgressionHumansMaleMiddle AgedAgalsidase alfaCognitive impairmentEnzyme replacement therapyFabry diseaseHasegawa dementia rating scaleHemodialysisMini-mental state examination

Identifiers

PMID38831308
PMCPMC11149238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.